“ Ultimately, we envision our competition as the disease rather than other companies ”
In Conversation
“ This is a very exciting moment for the Santen US affiliate ”
“ With rare disease patients and families deeply affected by COVID-19, important policy issues at a critical point and scientific innovation advancing more rapidly than at any… ”
“ Across research, development, and commercialization, our team is focused on advancing innovations that can address unmet needs, and we expect to see huge growth despite the… ”
“ We need to try and make sure that we are following the science [on COVID-19 vaccines] very closely, and refrain from getting lost in all the… ”
“ From my experience, many great ideas actually come from people unconstrained by the conventions and cultural uniformities of large organisations ”
“ We have learned that to perform well in the US, we need to have a consistently robust pipeline instead of relying on just one or two… ”
“ With our long history in brain diseases and our commitment to supporting people impacted by mental health disorders, we are uniquely positioned to lend our expertise… ”
“ At Novartis, we do not shy away from competition. It is a good thing and it demonstrates the attractiveness of the market. There is a reason… ”
“ The key priority for my tenure is to create sustainability, both for Amgen and for biosimilars more generally within the global market. ”
“ The most important element of any drug is whether it has a meaningful impact on patient outcomes. If you get that right, everything else takes care… ”
“ We have many programs currently in Phase III development. All these medicines are potentially transformative in nature. These are not ‘me too’ drugs that aim to… ”
